CoMFA study of novel phenyl ring-substituted 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter

Amy Hauck Newman, Sari E Izenwasser, Michael J. Robarge, Richard H. Kline

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A series of phenyl ring-substituted analogues of 3α- (diphenylmethoxy)tropane (benztropine) has been prepared as novel probes for the dopamine transporter. Cross-validated comparative molecular field analysis (CoMFA) models of the binding domain on the dopamine transporter were constructed using 37 geometry-optimized structures of these compounds and their corresponding binding affinities (K1 values) for the displacement of [3H]WIN 35,428 or potency of [3H]dopamine uptake inhibition (IC50 values) in rat caudate putamen tissue. The most predictive model (q2 = 0.78) correlated the steric component of CoMFA to the dependent variable of [3H]WIN 35,428 binding affinities. A novel series of seven phenyl ring- substituted analogues of 3α-(diphenylmethoxy)tropane was prepared, and our best molecular model was used to accurately predict their binding affinities. This study is the first to provide a CoMFA model for this class of dopamine uptake inhibitors. This model represents an advancement in the design of novel dopamine transporter ligands, based on 3α-(diphenylmethoxy)tropane, and further substantiates structure-activity relationships that have previously been proposed for this class of compounds. This CoMFA model can now be used to predict the binding affinities of novel 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter and will be useful in the design of molecular probes within this class of dopamine uptake inhibitors.

Original languageEnglish
Pages (from-to)3502-3509
Number of pages8
JournalJournal of Medicinal Chemistry
Volume42
Issue number18
DOIs
StatePublished - Sep 9 1999

Fingerprint

Tropanes
Dopamine Plasma Membrane Transport Proteins
Dopamine Uptake Inhibitors
Benztropine
Molecular Probes
Molecular Models
Putamen
Structure-Activity Relationship
Inhibitory Concentration 50
Dopamine
Ligands
Rats
Tissue
Geometry

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

CoMFA study of novel phenyl ring-substituted 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter. / Newman, Amy Hauck; Izenwasser, Sari E; Robarge, Michael J.; Kline, Richard H.

In: Journal of Medicinal Chemistry, Vol. 42, No. 18, 09.09.1999, p. 3502-3509.

Research output: Contribution to journalArticle

@article{b155d043116446c7a7cf75fc73030f1d,
title = "CoMFA study of novel phenyl ring-substituted 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter",
abstract = "A series of phenyl ring-substituted analogues of 3α- (diphenylmethoxy)tropane (benztropine) has been prepared as novel probes for the dopamine transporter. Cross-validated comparative molecular field analysis (CoMFA) models of the binding domain on the dopamine transporter were constructed using 37 geometry-optimized structures of these compounds and their corresponding binding affinities (K1 values) for the displacement of [3H]WIN 35,428 or potency of [3H]dopamine uptake inhibition (IC50 values) in rat caudate putamen tissue. The most predictive model (q2 = 0.78) correlated the steric component of CoMFA to the dependent variable of [3H]WIN 35,428 binding affinities. A novel series of seven phenyl ring- substituted analogues of 3α-(diphenylmethoxy)tropane was prepared, and our best molecular model was used to accurately predict their binding affinities. This study is the first to provide a CoMFA model for this class of dopamine uptake inhibitors. This model represents an advancement in the design of novel dopamine transporter ligands, based on 3α-(diphenylmethoxy)tropane, and further substantiates structure-activity relationships that have previously been proposed for this class of compounds. This CoMFA model can now be used to predict the binding affinities of novel 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter and will be useful in the design of molecular probes within this class of dopamine uptake inhibitors.",
author = "Newman, {Amy Hauck} and Izenwasser, {Sari E} and Robarge, {Michael J.} and Kline, {Richard H.}",
year = "1999",
month = "9",
day = "9",
doi = "10.1021/jm980701v",
language = "English",
volume = "42",
pages = "3502--3509",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "18",

}

TY - JOUR

T1 - CoMFA study of novel phenyl ring-substituted 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter

AU - Newman, Amy Hauck

AU - Izenwasser, Sari E

AU - Robarge, Michael J.

AU - Kline, Richard H.

PY - 1999/9/9

Y1 - 1999/9/9

N2 - A series of phenyl ring-substituted analogues of 3α- (diphenylmethoxy)tropane (benztropine) has been prepared as novel probes for the dopamine transporter. Cross-validated comparative molecular field analysis (CoMFA) models of the binding domain on the dopamine transporter were constructed using 37 geometry-optimized structures of these compounds and their corresponding binding affinities (K1 values) for the displacement of [3H]WIN 35,428 or potency of [3H]dopamine uptake inhibition (IC50 values) in rat caudate putamen tissue. The most predictive model (q2 = 0.78) correlated the steric component of CoMFA to the dependent variable of [3H]WIN 35,428 binding affinities. A novel series of seven phenyl ring- substituted analogues of 3α-(diphenylmethoxy)tropane was prepared, and our best molecular model was used to accurately predict their binding affinities. This study is the first to provide a CoMFA model for this class of dopamine uptake inhibitors. This model represents an advancement in the design of novel dopamine transporter ligands, based on 3α-(diphenylmethoxy)tropane, and further substantiates structure-activity relationships that have previously been proposed for this class of compounds. This CoMFA model can now be used to predict the binding affinities of novel 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter and will be useful in the design of molecular probes within this class of dopamine uptake inhibitors.

AB - A series of phenyl ring-substituted analogues of 3α- (diphenylmethoxy)tropane (benztropine) has been prepared as novel probes for the dopamine transporter. Cross-validated comparative molecular field analysis (CoMFA) models of the binding domain on the dopamine transporter were constructed using 37 geometry-optimized structures of these compounds and their corresponding binding affinities (K1 values) for the displacement of [3H]WIN 35,428 or potency of [3H]dopamine uptake inhibition (IC50 values) in rat caudate putamen tissue. The most predictive model (q2 = 0.78) correlated the steric component of CoMFA to the dependent variable of [3H]WIN 35,428 binding affinities. A novel series of seven phenyl ring- substituted analogues of 3α-(diphenylmethoxy)tropane was prepared, and our best molecular model was used to accurately predict their binding affinities. This study is the first to provide a CoMFA model for this class of dopamine uptake inhibitors. This model represents an advancement in the design of novel dopamine transporter ligands, based on 3α-(diphenylmethoxy)tropane, and further substantiates structure-activity relationships that have previously been proposed for this class of compounds. This CoMFA model can now be used to predict the binding affinities of novel 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter and will be useful in the design of molecular probes within this class of dopamine uptake inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0033539136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033539136&partnerID=8YFLogxK

U2 - 10.1021/jm980701v

DO - 10.1021/jm980701v

M3 - Article

C2 - 10479283

AN - SCOPUS:0033539136

VL - 42

SP - 3502

EP - 3509

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 18

ER -